Lanzul

Lansoprazole, the active ingredient in Lanzul, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is used to treat acid‑related disorders such as gastroesophageal reflux disease, peptic ulcer disease and Helicobacter pylori infection. GNH USA supplies Lanzul as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway, providing relief in several acid‑related disorders. - Gastroesophageal reflux disease (GERD): alleviates heartburn and esophageal irritation by lowering stomach acid. - Peptic ulcer disease: promotes ulcer healing and prevents recurrence by maintaining a less acidic gastric environment. - Helicobacter pylori eradication: used as part of combination therapy to eliminate H. pylori infection and reduce ulcer risk.

Adverse reactions may occur with Lanzul and should be monitored.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools, usually transient. - Nausea: feeling of stomach upset. - Abdominal pain: discomfort in the stomach area. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent diarrhea, abdominal cramping. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Liver enzyme elevation: signs of hepatitis, jaundice.

Before prescribing Lanzul, consider the following safety measures. - Assess renal function: adjust use in severe renal impairment. - Evaluate hepatic status: use with caution in liver disease. - Review concomitant medications: potential for drug interactions. - Monitor long‑term use: risk of vitamin B12 deficiency and bone fractures. - Pregnancy and lactation: discuss risks with the prescriber; data are limited. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Lanzul may interact with several medicines; awareness helps prevent reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Ketoconazole and itraconazole: markedly reduced antifungal absorption. - Atazanavir: decreased antiviral effectiveness. - Clopidogrel: reduced antiplatelet activity.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Digoxin: may increase serum levels, watch for toxicity. - Methotrexate: potential for increased toxicity, especially at high doses.